Oral Abstract Session
The Changing Landscape of Kidney Transplantation: Clinical Innovation, Outcomes, and Health Policy
October 23, 2026 | 04:30 PM - 06:00 PM
Location: Mile High Ballroom 4A, Convention Center
Session Description
Oral Abstract Session
Learning Pathway(s)
- Kidney Transplantation
Moderators
Presentations
Clinical Effectiveness of SGLT2 Inhibitors in Nondiabetic Kidney Transplant Recipients: A Real-World Data Analysis
Patient-Reported Outcomes in the Phase 2 BESTOW Trial Comparing Tegoprubart to Tacrolimus in Kidney Transplant Recipients
Deceased Donor Kidney Utilization and Outcomes Across Three Nationwide Allocation Systems: A 15-Year Analysis of More Than 400,000 Recovered Kidneys
Significant Increase and Variation in Organ Procurement Organization-Reported Deceased Donor Kidney Recovery Costs Between 2019 and 2024
Kidney Wait-Listing After Liver Transplant in the Safety Net Era: Evidence for Policy Reconsideration
Development and Internal Validation of a Risk Calculator for Postdonation eGFR Decline in Living Kidney Donors in Japan
Quantitative Glomerular Morphometry of Protocol Biopsies Predicts eGFR Decline in Living Donor Kidney Transplantation
Donation vs. Disease: eGFR-Based Cardiovascular Risk Among Living Kidney Donors vs. Nondonors
Preoperative CT-Based Whole-Kidney Volume Indexed to Body Surface Area Independently Predicts Postdonation CKD in Living Kidney Donors